Rite Aid Company Profile (NYSE:RAD)

About Rite Aid (NYSE:RAD)

Rite Aid logoRite Aid Corporation is a retail drugstore chain. The Company's segments include Retail Pharmacy and Pharmacy Services. The Company operates under The Rite Aid name. It operates approximately 4,560 stores in over 30 states across the country and in the District of Columbia. The Company's Retail Pharmacy segment consists of Rite Aid stores, RediClinic and Health Dialog. It sells brand and generic prescription drugs, as well as an assortment of front-end products, including health and beauty aids, personal care products, seasonal merchandise, and a private brand product line. Its front-end products include over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise and numerous other everyday and convenience products. The Company's Pharmacy Services segment consists of EnvisionRx, which provides a range of pharmacy benefit services.

Industry, Sector and Symbol:
  • Sector: Retail/Wholesale
  • Industry: Drug Stores
  • Sub-Industry: Drug Retail
  • Symbol: NYSE:RAD
  • CUSIP: 76775410
  • Web: www.riteaid.com
Capitalization:
  • Market Cap: $3.87 billion
  • Outstanding Shares: 1,053,684,000
Average Prices:
  • 50 Day Moving Avg: $4.04
  • 200 Day Moving Avg: $5.99
  • 52 Week Range: $3.32 - $8.77
P/E:
  • Trailing P/E Ratio: 917.50
  • Foreward P/E Ratio: 45.88
  • P/E Growth: 3.97
Sales & Book Value:
  • Annual Revenue: $32.85 billion
  • Price / Sales: 0.12
  • Book Value: $0.58 per share
  • Price / Book: 6.33
Profitability:
  • EBIDTA: $1.1 billion
  • Net Margins: 0.28%
  • Return on Equity: 24.52%
  • Return on Assets: 1.30%
Debt:
  • Debt-to-Equity Ratio: 11.22%
  • Current Ratio: 1.63%
  • Quick Ratio: 0.67%
Misc:
  • Average Volume: 19.25 million shs.
  • Beta: 1.89
  • Short Ratio: 1.97
 

Frequently Asked Questions for Rite Aid (NYSE:RAD)

What is Rite Aid's stock symbol?

Rite Aid trades on the New York Stock Exchange (NYSE) under the ticker symbol "RAD."

How were Rite Aid's earnings last quarter?

Rite Aid Co. (NYSE:RAD) issued its quarterly earnings data on Thursday, June, 16th. The company reported $0.01 earnings per share for the quarter, missing analysts' consensus estimates of $0.05 by $0.04. The firm earned $8.18 billion during the quarter, compared to analyst estimates of $8.23 billion. Rite Aid had a return on equity of 24.52% and a net margin of 0.28%. The company's revenue was up 23.1% on a year-over-year basis. During the same quarter last year, the company posted $0.02 EPS. View Rite Aid's Earnings History.

Where is Rite Aid's stock going? Where will Rite Aid's stock price be in 2017?

6 analysts have issued twelve-month target prices for Rite Aid's shares. Their forecasts range from $6.50 to $6.75. On average, they expect Rite Aid's share price to reach $6.58 in the next year. View Analyst Ratings for Rite Aid.

What are analysts saying about Rite Aid stock?

Here are some recent quotes from research analysts about Rite Aid stock:

  • 1. According to Zacks Investment Research, "Rite Aid posted solid fourth-quarter fiscal 2017, wherein both the top line and bottom line surpassed estimates, with sales breaking its five-quarter long negative surprise trend. Further, the company's stringent focus on cost management and strengthening its portfolio of health and wellness services also remain impressive. However, the company has underperformed the broader industry on a year-to-date basis due to the delay in the Rite Aid-Walgreens merger. After a delay and amendment to the offer in Jan 2017, Walgreens and Rite Aid recently certified substantial compliance with the U.S. FTC’s Second Request regarding the pending merger deal. While the merger will create a behemoth with solid network that will cater to health and wellness solutions both in stores and online, there’s no certainty about completion of the transaction. Moreover, risks related to industry consolidation and competition cannot be ignored." (5/16/2017)
  • 2. JPMorgan Chase & Co. analysts commented, "Yesterday, MGM hosted an investor day in Las Vegas, where management provided an overview of the company’s financial outlook/guidance, its positive outlook for Las Vegas, an update on its construction projects, and various examples of how they are driving efficiency and innovating. By 2019, the company expects to achieve $4.0b of adjusted EBITDA (15%+ CAGR) and $2.075b of adjusted free cash flow (after all capex). The company also expects to achieve an investment grade credit rating, with net leverage seen declining to the low ~4x range in 2017 and low ~3x range in 2018 (pro forma 1Q16 net leverage: 4.8x). Additionally, MGM upsized its profit growth plan by $100m, now seeing $400m in savings and low 30% wholly owned domestic EBITDA margins by 2017, and also reiterated its expectation for 6%+ 2016 RevPAR growth. Given MGM’s strong operating trends, pipeline of upcoming projects, and compelling valuation of 9.3x our 2017E EBITDA, we continue to see value in the shares and reiterate our Overweight rating and $30 price target." (6/17/2016)

Are investors shorting Rite Aid?

Rite Aid saw a decrease in short interest during the month of April. As of April 28th, there was short interest totalling 35,184,050 shares, a decrease of 11.1% from the April 13th total of 39,589,727 shares. Based on an average daily trading volume, of 20,935,298 shares, the short-interest ratio is presently 1.7 days. Currently, 3.4% of the shares of the company are sold short.

Who are some of Rite Aid's key competitors?

Who are Rite Aid's key executives?

Rite Aid's management team includes the folowing people:

  • John T. Standley, Chairman of the Board, Chief Executive Officer
  • Kenneth A. Martindale, President - Rite Aid Corporation, Chief Executive Officer - Rite Aid stores
  • Darren W. Karst, Chief Financial Officer, Senior Executive Vice President, Chief Administrative Officer
  • Ken Black, Chief Human Resource Officer, Senior Vice President
  • David Abelman, Executive Vice President - Marketing
  • Bryan Everett, Executive Vice President - Store Operations
  • Jocelyn Z. Konrad, Executive Vice President - Pharmacy
  • Enio Anthony Montini Jr., Executive Vice President - Merchandising and Distribution
  • Douglas E. Donley, Chief Accounting Officer, Senior Vice President
  • James Joseph Comitale, Senior Vice President, General Counsel, Secretary

Who owns Rite Aid stock?

Rite Aid's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (8.07%), BlackRock Inc. (4.83%), State Street Corp (1.91%), APG Asset Management N.V. (1.46%), FMR LLC (0.92%) and Morgan Stanley (0.84%). Company insiders that own Rite Aid stock include Douglas E Donley and Tony Montini. View Institutional Ownership Trends for Rite Aid.

Who sold Rite Aid stock? Who is selling Rite Aid stock?

Rite Aid's stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, M&T Bank Corp, UBS Group AG, OppenheimerFunds Inc., Marshall Wace LLP, Los Angeles Capital Management & Equity Research Inc., TIAA CREF Investment Management LLC and Edmond DE Rothschild Holding S.A.. View Insider Buying and Selling for Rite Aid.

Who bought Rite Aid stock? Who is buying Rite Aid stock?

Rite Aid's stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., APG Asset Management N.V., Vanguard Group Inc., Symons Capital Management Inc., Credit Suisse AG, Coronation Fund Managers Ltd., CI Global Investments Inc. and State Street Corp. View Insider Buying and Selling for Rite Aid.

How do I buy Rite Aid stock?

Shares of Rite Aid can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Rite Aid's stock price today?

One share of Rite Aid stock can currently be purchased for approximately $3.67.


MarketBeat Community Rating for Rite Aid (NYSE RAD)
Community Ranking:  2.7 out of 5 ( )
Outperform Votes:  231 (Vote Outperform)
Underperform Votes:  204 (Vote Underperform)
Total Votes:  435
MarketBeat's community ratings are surveys of what our community members think about Rite Aid and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Rite Aid (NYSE:RAD) (?)
Ratings Breakdown: 4 Hold Ratings, 2 Buy Ratings
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $6.58 (79.38% upside)

Analysts' Ratings History for Rite Aid (NYSE:RAD)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
4/25/2017GuggenheimDowngradeBuy -> NeutralMediumView Rating Details
3/20/2017Credit Suisse Group AGReiterated RatingOutperform$6.50LowView Rating Details
3/6/2017Deutsche Bank AGReiterated RatingHold$9.00 -> $6.50N/AView Rating Details
1/31/2017MizuhoLower Price Target$6.75N/AView Rating Details
6/17/2016JPMorgan Chase & Co.Reiterated RatingHoldN/AView Rating Details
6/1/2016Evercore ISIDowngradeBuy -> HoldN/AView Rating Details
1/7/2016Jefferies Group LLCBoost Price TargetHold$9.00N/AView Rating Details
10/29/2015Goldman Sachs Group IncDowngradeBuy -> Neutral$9.00 -> $9.00N/AView Rating Details
10/15/2015Cowen and CompanyLower Price TargetBuy$11.00 -> $10.00N/AView Rating Details
9/18/2015S&P Equity ResearchReiterated RatingBuy$10.00 -> $9.00N/AView Rating Details
8/13/2015Bank of America CorpInitiated CoverageBuy$11.00N/AView Rating Details
7/10/2015Raymond James Financial, Inc.DowngradeOutperform -> Market PerformN/AView Rating Details
(Data available from 5/29/2015 forward)

Earnings

Earnings History for Rite Aid (NYSE:RAD)
Earnings by Quarter for Rite Aid (NYSE:RAD)
Earnings History by Quarter for Rite Aid (NYSE:RAD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
12/22/2016Q317$0.04$0.02$8.23 billion$8.09 billionViewN/AView Earnings Details
9/22/2016Q2$0.03$0.03$8.09 billion$8.03 billionViewN/AView Earnings Details
6/16/2016Q117$0.05$0.01$8.23 billion$8.18 billionViewN/AView Earnings Details
4/7/2016Q416$0.06$0.07$8.47 billion$8.27 billionViewN/AView Earnings Details
12/17/2015Q316$0.06$0.06$8.20 billion$8.15 billionViewN/AView Earnings Details
9/17/2015Q216$0.03$0.02$7.60 billion$7.66 billionViewListenView Earnings Details
6/18/2015Q116$0.03$0.04$6.65 billion$6.60 billionViewListenView Earnings Details
4/8/2015Q415$0.07$0.12$6.79 billion$6.85 billionViewN/AView Earnings Details
12/18/2014Q315$0.05$0.10$6.55 billion$6.70 billionViewListenView Earnings Details
9/18/2014Q215$0.06$0.13$6.49 billion$6.52 billionViewListenView Earnings Details
6/19/2014Q115$0.05$0.04$6.43 billion$6.47 billionViewListenView Earnings Details
4/10/2014Q414$0.04$0.10$6.54 billion$6.60 billionViewListenView Earnings Details
12/19/2013Q314$0.04$0.04$6.30 billion$6.36 billionViewListenView Earnings Details
9/19/2013Q2 2014($0.04)$0.03$6.27 billion$6.30 billionViewListenView Earnings Details
6/20/2013Q1 2014$0.09$0.09$6.27 billion$6.30 billionViewListenView Earnings Details
4/11/2013Q4 2013($0.02)$0.13$6.47 billion$6.50 billionViewListenView Earnings Details
12/20/2012Q3 2013($0.03)$0.07$6.28 billion$6.24 billionViewListenView Earnings Details
9/20/2012Q213($0.07)($0.05)$6.20 billion$6.20 billionViewN/AView Earnings Details
6/21/2012($0.03)($0.03)ViewN/AView Earnings Details
4/12/2012($0.17)($0.18)ViewN/AView Earnings Details
12/15/2011($0.13)($0.06)ViewN/AView Earnings Details
9/22/2011($0.17)($0.11)ViewN/AView Earnings Details
6/23/2011($0.12)($0.07)ViewN/AView Earnings Details
4/7/2011($0.24)($0.24)ViewN/AView Earnings Details
12/16/2010($0.13)($0.09)$6.20 billion$6.20 billionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Rite Aid (NYSE:RAD)
2017 EPS Consensus Estimate: $0.18
2018 EPS Consensus Estimate: $0.22
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$0.06$0.06$0.06
Q2 20171$0.04$0.04$0.04
Q3 20171$0.08$0.08$0.08
Q1 20181$0.03$0.03$0.03
Q2 20181$0.04$0.04$0.04
Q3 20181$0.08$0.08$0.08
Q4 20181$0.07$0.07$0.07
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Rite Aid (NYSE:RAD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Rite Aid (NYSE:RAD)
Insider Ownership Percentage: 2.33%
Institutional Ownership Percentage: 59.92%
Insider Trades by Quarter for Rite Aid (NYSE:RAD)
Institutional Ownership by Quarter for Rite Aid (NYSE:RAD)
Insider Trades by Quarter for Rite Aid (NYSE:RAD)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/15/2016Douglas E DonleySVPSell34,106$7.77$265,003.62View SEC Filing  
7/9/2015Tony MontiniEVPSell353,194$8.38$2,959,765.72View SEC Filing  
4/15/2015Joseph B Anderson JrDirectorSell150,000$8.25$1,237,500.00View SEC Filing  
4/13/2015Robert K ThompsonEVPSell95,850$8.33$798,430.50View SEC Filing  
4/10/2015Douglas E DonleyCAOSell59,404$8.21$487,706.84View SEC Filing  
4/10/2015Marcy SymsDirectorSell150,000$8.26$1,239,000.00View SEC Filing  
12/29/2014Tony MontiniEVPSell49,525$7.47$369,951.75View SEC Filing  
12/23/2014Tony MontiniEVPSell259,750$6.92$1,797,470.00View SEC Filing  
12/22/2014John T StandleyCEOSell1,700,000$6.82$11,594,000.00View SEC Filing  
12/22/2014Kenneth MartindaleCOOSell1,043,400$6.80$7,095,120.00View SEC Filing  
12/22/2014Robert Ivan ThompsonEVPSell149,231$6.80$1,014,770.80View SEC Filing  
7/3/2014Robert Ivan ThompsonEVPSell249,583$7.48$1,866,880.84View SEC Filing  
6/24/2014Joseph B Anderson JrDirectorSell26,667$7.05$188,002.35View SEC Filing  
6/23/2014Robert Ivan ThompsonEVPSell510,000$7.06$3,600,600.00View SEC Filing  
4/22/2014Marc StrasslerEVPSell224,800$7.12$1,600,576.00View SEC Filing  
4/21/2014Frank VitranoEVPSell1,913,925$7.08$13,550,589.00View SEC Filing  
4/16/2014Robert Ivan ThompsonEVPSell25,566$7.03$179,728.98View SEC Filing  
2/19/2014John StandleyCEOSell1,200,000$6.23$7,476,000.00View SEC Filing  
2/19/2014Kenneth MartindaleCOOSell666,667$6.23$4,153,335.41View SEC Filing  
1/21/2014Douglas DonleySVPSell24,173$5.79$139,961.67View SEC Filing  
1/3/2014John StandleyCEOSell600,000$5.48$3,288,000.00View SEC Filing  
1/3/2014Kenneth MartindaleCOOSell333,333$5.48$1,826,664.84View SEC Filing  
10/18/2013Robert K ThompsonEVPSell250,000$5.27$1,317,500.00View SEC Filing  
10/17/2013Douglas E DonleySVPSell88,700$5.27$467,449.00View SEC Filing  
10/17/2013Marc A StrasslerEVPSell100,000$5.31$531,000.00View SEC Filing  
10/14/2013Frank VitranoCFOSell1,982,900$5.00$9,914,500.00View SEC Filing  
10/4/2013Tony MontiniEVPSell414,500$5.21$2,159,545.00View SEC Filing  
9/25/2013Robert Ivan ThompsonEVPSell400,000$4.81$1,924,000.00View SEC Filing  
7/18/2013Robert K ThompsonEVPSell401,655$3.01$1,208,981.55View SEC Filing  
7/16/2013David JessickInsiderSell100,000$2.93$293,000.00View SEC Filing  
7/16/2013Marc A StrasslerEVPSell375,000$2.96$1,110,000.00View SEC Filing  
7/12/2013Douglas E DonleySVPSell6,899$2.80$19,317.20View SEC Filing  
7/11/2013Douglas E DonleySVPSell75,378$2.78$209,550.84View SEC Filing  
7/11/2013Robert Ivan ThompsonEVPSell375,000$2.75$1,031,250.00View SEC Filing  
6/26/2013Jean Coutu Group (Pjc) Inc.Major ShareholderSell40,500,000$2.75$111,375,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Rite Aid (NYSE:RAD)
Latest Headlines for Rite Aid (NYSE:RAD)
Source:
DateHeadline
investorplace.com logoRite Aid Corporation (NYSE:RAD) Stock Isn’t Worth Chasing
investorplace.com - May 28 at 8:37 AM
investorplace.com logoRite Aid Corporation (NYSE:RAD) Stock Isn’t Worth Chasing
investorplace.com - May 28 at 8:30 AM
americanbankingnews.com logoRite Aid Co. (RAD) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - May 26 at 6:47 PM
americanbankingnews.com logoRite Aid Target of Unusually Large Options Trading (RAD)
www.americanbankingnews.com - May 25 at 7:14 AM
fool.com logoCan Rite Aid Stock Bounce Back After Last Week's 12% Drop ... - Motley Fool
www.fool.com - May 23 at 9:43 AM
finance.yahoo.com logoETFs with exposure to Rite Aid Corp. : May 22, 2017
finance.yahoo.com - May 22 at 6:33 PM
finance.yahoo.com logoHealth Dialog Provides Nurse Line Services to Kern Health Systems' Population Health Program
finance.yahoo.com - May 22 at 9:27 AM
finance.yahoo.com logoCan Rite Aid Stock Bounce Back After Last Week's 12% Drop?
finance.yahoo.com - May 21 at 6:29 PM
fool.com logoCan Rite Aid Stock Bounce Back After Last Week's 12% Drop?
www.fool.com - May 21 at 12:20 PM
finance.yahoo.com logoAmazon is breaking into the pharmacy market
finance.yahoo.com - May 19 at 12:18 PM
finance.yahoo.com logoOptions Traders Expect Huge Moves in Rite Aid (RAD) Stock
finance.yahoo.com - May 19 at 12:18 PM
finance.yahoo.com logoDavid Einhorn's Greenlight Capital First-Quarter Commentary 2017
finance.yahoo.com - May 17 at 7:21 PM
investorplace.com logoRite Aid Corporation (RAD) Stock Isn’t Worth the Headache
investorplace.com - May 17 at 1:01 PM
investorplace.com logoRite Aid Corporation (RAD) Stock Isn’t Worth the Headache
investorplace.com - May 17 at 12:58 PM
investorplace.com logoWhy Rite Aid Corporation (RAD) Stock Can Hold Its Own - Investorplace.com
investorplace.com - May 17 at 8:04 AM
fool.com logoRite Aid Shares Slide 8% After Report of Increased FTC Activity
www.fool.com - May 16 at 5:44 PM
investorplace.com logoWhy Dicks Sporting Goods Inc (DKS), Rite Aid Corporation (RAD) and Davita Inc (DVA) Are 3 of Today’s Worst Stocks
investorplace.com - May 16 at 4:54 PM
americanbankingnews.com logoRite Aid Co. (RAD) Lifted to Hold at Zacks Investment Research
www.americanbankingnews.com - May 16 at 12:56 PM
investorplace.com logoWhy Rite Aid Corporation (RAD) Stock Can Hold Its Own
investorplace.com - May 15 at 3:04 PM
americanbankingnews.com logoRite Aid Co. (RAD) Short Interest Down 11.1% in April
www.americanbankingnews.com - May 15 at 7:40 AM
seekingalpha.com logoShould Walgreens Leave Rite Aid At The Merger Altar?
seekingalpha.com - May 12 at 12:53 AM
investorplace.com logoRite Aid Corporation (RAD) Won't Do Much for Walgreens - Investorplace.com
investorplace.com - May 11 at 8:22 AM
americanbankingnews.com logoRite Aid Sees Unusually High Options Volume (RAD)
www.americanbankingnews.com - May 11 at 7:46 AM
americanbankingnews.com logoStock Traders Buy Large Volume of Put Options on Rite Aid (RAD)
www.americanbankingnews.com - May 11 at 7:46 AM
finance.yahoo.com logoJ. P. Morgan Commercial Mortgage Finance Corp. 2000-C9 -- Moody's Affirms Two Classes of JPMC 2000-C9
finance.yahoo.com - May 10 at 7:40 PM
investorplace.com logoRite Aid Corporation (RAD) Won’t Do Much for Walgreens
investorplace.com - May 10 at 12:34 PM
bizjournals.com logo7 things to know today and $90M Creative Village project gets first city approval
www.bizjournals.com - May 10 at 11:20 AM
finance.yahoo.com logoETFs with exposure to Rite Aid Corp. : May 9, 2017
finance.yahoo.com - May 9 at 6:59 PM
investorplace.com logoRite Aid Corporation (RAD) Stock Is a Gamble, But It’s Worth the Jackpot
investorplace.com - May 9 at 1:57 PM
investorplace.com logoRite Aid Corporation (RAD) Stock Is a Gamble, But It’s Worth the Jackpot
investorplace.com - May 9 at 1:43 PM
finance.yahoo.com logoHealth Dialog and National Electric Cooperative to Share Successful Strategies for 10-Year Population Health Program
finance.yahoo.com - May 9 at 10:53 AM
finance.yahoo.com logoWalgreens Boots Alliance and Rite Aid Certify Substantial Compliance with Second Request
finance.yahoo.com - May 8 at 6:48 PM
finance.yahoo.com logoWalgreens, Rite Aid To Certify Compliance, Forcing FTC's Hand On Merger
finance.yahoo.com - May 8 at 6:48 PM
finance.yahoo.com logoRite Aid Corp. :RAD-US: Earnings Analysis: Q4, 2017 By the Numbers : May 8, 2017
finance.yahoo.com - May 8 at 11:52 AM
americanbankingnews.com logoRite Aid (RAD) Earns News Sentiment Rating of 0.20
www.americanbankingnews.com - May 4 at 1:09 AM
finance.yahoo.com logoRite Aid Corp (RAD) Files 10-K for the Fiscal Year Ended on February 28, 2017
finance.yahoo.com - May 4 at 12:34 AM
seekingalpha.com logoIs Walgreens Pushing FTC On The Rite Aid Deal? - Seeking Alpha
seekingalpha.com - May 2 at 9:53 AM
americanbankingnews.com logoRite Aid Co. (RAD) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - May 1 at 9:20 PM
americanbankingnews.com logoShort Interest in Rite Aid Co. (RAD) Declines By 6.7%
www.americanbankingnews.com - May 1 at 8:11 AM
americanbankingnews.com logoRite Aid (RAD) Earns Daily Coverage Optimism Rating of 0.06
www.americanbankingnews.com - April 30 at 4:11 PM
investorplace.com logoRite Aid Corporation (RAD) Shareholders Need to Move On
investorplace.com - April 28 at 11:48 AM
americanbankingnews.com logoSomewhat Favorable Media Coverage Likely to Affect Rite Aid (RAD) Share Price
www.americanbankingnews.com - April 28 at 1:01 AM
finance.yahoo.com logoRite Aid Q4 Earnings Review, Price Target Consensus and Walgreens Merger Status - Yahoo Finance
finance.yahoo.com - April 27 at 10:49 AM
finance.yahoo.com logoRite Aid Q4 Earnings Review, Price Target Consensus and Walgreens Merger Status
finance.yahoo.com - April 27 at 10:48 AM
finance.yahoo.com logoCompany News for April 26, 2017
finance.yahoo.com - April 26 at 5:50 PM
finance.yahoo.com logo[$$] Rite Aid Shares Jump After Earnings Beat
finance.yahoo.com - April 25 at 6:32 PM
americanbankingnews.com logoRite Aid Co. (RAD) Stock Rating Lowered by Guggenheim
www.americanbankingnews.com - April 25 at 3:07 PM
finance.yahoo.com logoHow Investors Are Trading Rite Aid Ahead of Earnings
finance.yahoo.com - April 25 at 10:17 AM
finance.yahoo.com logoRite Aid Reports Fiscal 2017 Fourth Quarter and Full Year Results
finance.yahoo.com - April 25 at 10:17 AM
finance.yahoo.com logoRite Aid shares jump after earnings beat
finance.yahoo.com - April 25 at 10:17 AM

Social

Chart

Rite Aid (RAD) Chart for Monday, May, 29, 2017

This page was last updated on 5/29/2017 by MarketBeat.com Staff